Advertisement INC Research acquires Trident Clinical Research - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

INC Research acquires Trident Clinical Research

INC Research, a contract research organization (CRO), has acquired Trident Clinical Research to expand its clinical trials outsourcing in Australia, New Zealand and India.

Following the acquisition, Trident will become the wholly owned subsidiary of INC Research and will be operating as Trident Clinical Research, an INC Research company, through its offices in Sydney, Brisbane, Melbourne, Adelaide, Auckland and Mumbai.

Trident Clinical Research managing director and co-founder Garth Tierney said they look forward to leveraging INC Research’s resources and Trusted Process methodology to enhance their services.